Works about TARDIVE dyskinesia

Results: 1052

Long‐term treatment with valbenazine improves TD in elderly adults.

Published in:: Brown University Psychopharmacology Update, 2025, v. 36, n. 8, p. 8, doi. 10.1002/pu.31342
Publication type:: Article

Hyper-dopaminergic ballismus and respiratory dyskinesia treated with intravenous haloperidol.

Published in:

Emergency Medicine Australasia, 2014, v. 26, n. 6, p. 647, doi. 10.1111/1742-6723.12317

By:

McLay, Stuart VB;
MacDonald, Stephen PJ

Publication type:

Article

Education initiative improves the evidence-based use of metoclopramide following morphine administration in the emergency department.

Published in:

Emergency Medicine Australasia, 2009, v. 21, n. 3, p. 178, doi. 10.1111/j.1742-6723.2009.01179.x

By:

Yeoh, Bernard S. K.;
McD Taylor, David;
Taylor, Simone E.

Publication type:

Article

Levetirasetam Kullanımı ile İlişkili Psikotik Bozukluk: İki Olgu sunumu.

Published in:

2009

By:

Erdoğan, Serap;
Aslan, Selçuk;
Yüksel, Nevzat

Publication type:

Case Study

Olanzapine Y ol CII Tardive Discontinuing, Clozapine Ile Treedaisy.

Published in:

Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S262

By:

Ozan, Erol;
Oral, Elif;
Daloğlu, Ali Gökhan;
Aydın, Nazan;
Kırpınar, İsmet

Publication type:

Article

Aripiprazol'un Neden Olduğu Akut Distoni ve Akatizi: Bir Olgu Sunumu.

Published in:

Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S259

By:

Göka, Erol;
Yalçın, Demet Özen;
Akdemir, Cemal;
Kısa, Cebrail

Publication type:

Article

Uzun Etkili Enjektabl Risperidon Kullanımına Bağlı Geliş:en Tardiv Diskinezi: Bir Olgu Bildirimi.

Published in:

Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S191

By:

Durmaz, Onur;
Ateş, M. Alpay;
Algül, Ayhan;
Gülsün, Murat

Publication type:

Article

İkiuçlu Bozuklukta Aripiprazol.

Published in:

Klinik Psikofarmakoloji Bulteni, 2008, v. 18, p. S27

By:

Uluşahin, Aylin

Publication type:

Article

Şizofreni Tedavisinde Uzun Etkili Risperidon: Geriye Dönük Bir Çalışma.

Published in:

Klinik Psikofarmakoloji Bulteni, 2007, v. 17, n. 3, p. 119

By:

Yumru, Mehmet;
Savaş, Haluk A.;
Kokaçya, M. Hanifi;
Vırıt, Osman

Publication type:

Article

İlaca Bağlı Geç Başlangıçlı Hareket Bozuklukları.

Published in:

Klinik Psikofarmakoloji Bulteni, 2006, v. 16, n. 4, p. 263

By:

Öztürk, Oya;
Kurt, Erhan;
Oral, Timuçin

Publication type:

Article

Valproata Ek Olarak Düflük Doz Olanzapin Kullaımına Bağ Şiddetli Ekstrapiramidal Bulgular: Bir Olgu.

Published in:

Klinik Psikofarmakoloji Bulteni, 2006, v. 16, n. 1, p. 42

By:

Demet Dankı;
Dilbaz, Nesrin;
Okay, İhsan Tuncer

Publication type:

Article

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 9, doi. 10.1002/pu.30945
Publication type:: Article

LAI antipsychotics associated with lower risk of TD than oral versions.

Published in:: Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 3, doi. 10.1002/pu.30938
Publication type:: Article

Trial‐ineligible patients with schizophrenia have higher risk of adverse outcomes.

Published in:: Brown University Psychopharmacology Update, 2022, v. 33, n. 5, p. 3, doi. 10.1002/pu.30866
Publication type:: Article

Deutetrabenazine safe and effective for tardive dyskinesia in adults, regardless of age.

Published in:: Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 6, doi. 10.1002/pu.30843
Publication type:: Article

Several drugs show effectiveness in treating tardive dyskinesia.

Published in:: Brown University Psychopharmacology Update, 2020, v. 31, n. 10, p. 7, doi. 10.1002/pu.30634
Publication type:: Article

Deutetrabenazine shows long‐term effectiveness for tardive dyskinesia.

Published in:: Brown University Psychopharmacology Update, 2019, v. 30, n. 11, p. 4, doi. 10.1002/pu.30497
Publication type:: Article

Second‐generation antipsychotics show longer‐lasting benefits for cognition in schizophrenia.

Published in:: Brown University Psychopharmacology Update, 2019, v. 30, n. 8, p. 3, doi. 10.1002/pu.30458
Publication type:: Article

Meta‐analysis: Advantage for second‐generation antipsychotics on TD risk.

Published in:: Brown University Psychopharmacology Update, 2019, v. 30, n. 1, p. 3, doi. 10.1002/pu.30384
Publication type:: Article

Antidepressants and extrapyramidal symptoms.

Published in:

Brown University Psychopharmacology Update, 2018, v. 29, n. 12, p. 2, doi. 10.1002/pu.30376

By:

Lam, Y. W. Francis

Publication type:

Article

Two doses of deutetrabenazine show efficacy over placebo in treating tardive dyskinesia.

Published in:: Brown University Psychopharmacology Update, 2017, v. 28, n. 11, p. 3, doi. 10.1002/pu.30273
Publication type:: Article

The VMAT2 inhibitors: New hope for an old scourge.

Published in:

Brown University Psychopharmacology Update, 2017, v. 28, n. 11, p. 5, doi. 10.1002/pu.30274

By:

Price, Lawrence H.

Publication type:

Article

Phase 3 study finds once-daily valbenazine improves symptoms of tardive dyskinesia.

Published in:: Brown University Psychopharmacology Update, 2017, v. 28, n. 7, p. 1, doi. 10.1002/pu.30240
Publication type:: Article

Approvals.

Published in:: Brown University Psychopharmacology Update, 2017, v. 28, n. 7, p. 8, doi. 10.1002/pu.30246
Publication type:: Article

Risk of extrapyramidal reactions with aripiprazole.

Published in:

Brown University Psychopharmacology Update, 2017, v. 28, n. 1, p. 2, doi. 10.1002/pu.30197

By:

Lam, Y. W. Francis

Publication type:

Article

Paliperidone Invega.

Published in:: Brown University Psychopharmacology Update, 2015, v. 26, p. 1
Publication type:: Article

Aripiprazole (generic)/ABILIFY (BRAND).

Published in:: Brown University Psychopharmacology Update, 2014, v. 25, p. 1
Publication type:: Article

Intermittent antipsychotic treatment not as effective as continuous.

Published in:: Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 7
Publication type:: Article

YOUR MEDICATION INFORMATION. Lurasidone (generic) LATUDA (BRAND).

Published in:: Brown University Psychopharmacology Update, 2013, v. 24, p. 1, doi. 10.1002/pu.20192
Publication type:: Article

YOUR MEDICATION INFORMATION. Olanzapine (generic) ZYPREXA (BRAND).

Published in:: Brown University Psychopharmacology Update, 2013, v. 24, p. 1, doi. 10.1002/pu.20192
Publication type:: Article

YOUR MEDICATION INFORMATION: Clozapine (generic) CLOZARIL (BRAND).

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, p. 1, doi. 10.1002/pu.20156
Publication type:: Article

YOUR MEDICATION INFORMATION.

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, p. 1, doi. 10.1002/pu.20156
Publication type:: Article

YOUR MEDICATION INFORMATION. Paliperidone (generic) INVEGA (BRAND).

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, p. 1, doi. 10.1002/pu.20156
Publication type:: Article

YOUR MEDICATION INFORMATION. Lurasidone (generic) LATUDA (BRAND).

Published in:: Brown University Psychopharmacology Update, 2011, p. 1
Publication type:: Article

Atypical antipsychotics and tardive dyskinesia: Caution still indicated.

Published in:: Brown University Psychopharmacology Update, 2011, v. 22, n. 8, p. 1
Publication type:: Article

Drug-Induced Movement Disorders.

Published in:

Journal of Pharmacy Practice, 2007, v. 20, n. 6, p. 415, doi. 10.1177/0897190007310514

By:

Claxton, Katherine L.;
Chen, Jack J.;
Swope, David M.

Publication type:

Article

A Case Report of Lurasidone-Induced Tardive Dyskinesia: Therapeutic Role of Valbenazine.

Published in:

2024

By:

Jha, Ambika Nand;
Gaikwad, Varsha Ratan

Publication type:

Case Study

Clinical and demographic features of acutely hospitalised schizophrenia patients according to Toxoplasma gondii serostatus.

Published in:

European Journal of Translational & Clinical Medicine, 2023, v. 6, n. 1, p. 14, doi. 10.31373/ejtcm/162759

By:

Grabowski, Jakub;
Waszak, Przemysław;
Przybylak, Mateusz;
Bidzan, Leszek

Publication type:

Article

Deep Brain Stimulation in the Treatment of Tardive Dyskinesia.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1868, doi. 10.3390/jcm12051868

By:

Szczakowska, Adrianna;
Gabryelska, Agata;
Gawlik-Kotelnicka, Oliwia;
Strzelecki, Dominik

Publication type:

Article

Tardive Syndrome Is a Mysterious Phenomenon with Different Clinical Manifestations—Review.

Published in:

2023

By:

Badarny, Samih;
Nassar, Rima;
Badarny, Yazid

Publication type:

Case Study

Review of Dopamine Antagonists for Nausea and Vomiting in Palliative Care Patients.

Published in:

Journal of Pain & Palliative Care Pharmacotherapy, 2024, v. 38, n. 1, p. 38, doi. 10.1080/15360288.2023.2268065

By:

Jenkins, Grace

Publication type:

Article

A Case of Tardive Dyskinesia in the Last Weeks of Life.

Published in:

Journal of Pain & Palliative Care Pharmacotherapy, 2015, v. 29, n. 2, p. 144, doi. 10.3109/15360288.2015.1035833

By:

Yehl, Jennifer L.;
Sheyner, Inna;
Fasnacht, Kathleen S.;
Stewart, Jonathan T.

Publication type:

Article

A tardive dyskinesia drug target VMAT-2 participates in neuronal process elongation.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-97308-5

By:

Ishida, Miki;
Ichikawa, Ryuya;
Ohbuchi, Katsuya;
Oizumi, Hiroaki;
Miyamoto, Yuki;
Yamauchi, Junji

Publication type:

Article

Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/ PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.

Published in:

Scientific Reports, 2014, p. 1, doi. 10.1038/srep07506

By:

Cheng-long Xie;
Wen-Wen Wang;
Su-fang Zhang;
Ming-Lu Yuan;
Jun-Yi Che;
Jing Gan;
Lu Song;
Wei-En Yuan;
Zhen-Guo Liu

Publication type:

Article

Real-world safety analysis of deutetrabenazine post-marketing: a disproportionality study leveraging the FDA Adverse Event Reporting System (FAERS) database.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00872-9

By:

Qing, Guangwei;
Ye, Shiyi;
Wei, Bo;
Yang, Yuanjian

Publication type:

Article

A Bioequivalence Comparison Between the Once‐Daily Extended‐Release Tablet and the Twice‐Daily Tablet Formulations of Deutetrabenazine at Steady State.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 3, p. 224, doi. 10.1002/cpdd.1355

By:

Sunzel, Eva‐Maria;
Rabinovich‐Guilatt, Laura;
Iyengar, Malini;
Ruffo, Debra;
Birajdar, Nagnath G.;
Loupe, Pippa;
Gutierrez, Maria;
Gordon, Mark Forrest;
Ghibellini, Giulia

Publication type:

Article

Pharmacokinetic and Pharmacologic Characterization of the Dihydrotetrabenazine Isomers of Deutetrabenazine and Valbenazine.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 4, p. 447, doi. 10.1002/cpdd.1205

By:

Brar, Satjit;
Vijan, Arjun;
Scott, Fiona L.;
Jimenez, Roland;
Zhang, Hui;
Grigoriadis, Dimitri E.;
Loewen, Gordon

Publication type:

Article

Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration‐QTc Analysis.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 94, doi. 10.1002/cpdd.1161

By:

Schneider, Frank;
Darpo, Borje;
Loupe, Pippa S.;
Xue, Hongqi;
Knebel, Helena;
Gutierrez, Maria;
Gordon, Mark Forrest;
Rabinovich‐Guilatt, Laura

Publication type:

Article

Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 647, doi. 10.1002/cpdd.882

By:

Schneider, Frank;
Stamler, David;
Bradbury, Margaret;
Loupe, Pippa S.;
Hellriegel, Edward;
Cox, Donna S.;
Savola, Juha‐Matti;
Gordon, Mark Forrest;
Rabinovich‐Guilatt, Laura

Publication type:

Article

A case of dysgraphia induced by sertraline and a review of official spontaneous adverse reaction databases.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 1, p. 106, doi. 10.1111/jcpt.12356

By:

Gentili, M.;
Marinaccio, P. M.;
Galimberti, C.;
Carnovale, C.;
Antoniazzi, S.;
Pozzi, M.;
Clementi, E.;
Viganò, C.;
Radice, S.

Publication type:

Article